Safety of multicomponent meningococcal group B vaccine
Listen to The Lancet Child & Adolescent Health
English - April 26, 2018 06:30 - 9 minutesScience Health & Fitness Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Adolescent-to-parent abuse
Next Episode: Treatment of paediatric narcolepsy with sodium oxybate
Philip Bryan joins The Lancet Child & Adolescent Health to discuss the safety of multicomponent meningococcal group B vaccine (4CMenB) in the UK’s infant immunisation programme.